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Retinitis pigmentosa (RP) is a progressive retinal dystrophy that causes visual
impairment and eventual blindness. Retinal prostheses are the best currently available
vision-restoring treatment for RP, but only restore crude vision. One possible contributing
factor to the poor quality of vision achieved with prosthetic devices is the pathological
retinal ganglion cell (RGC) hyperactivity that occurs in photoreceptor dystrophic
disorders. Gap junction blockade with meclofenamic acid (MFA) was recently shown
to diminish RGC hyperactivity and improve the signal-to-noise ratio (SNR) of RGC
responses to light flashes and electrical stimulation in the rd10 mouse model of RP. We
sought to extend these results to spatiotemporally patterned optogenetic stimulation
in the faster-degenerating rd1 model and compare the effectiveness of a number of
drugs known to disrupt rd1 hyperactivity. We crossed rd1 mice with a transgenic
mouse line expressing the light-sensitive cation channel channelrhodopsin2 (ChR2) in
RGCs, allowing them to be stimulated directly using high-intensity blue light. We used
60-channel ITO multielectrode arrays to record ChR2-mediated RGC responses from
wholemount, ex-vivo retinas to full-field and patterned stimuli before and after application
of MFA, 18-β-glycyrrhetinic acid (18BGA, another gap junction blocker) or flupirtine (Flu,
a Kv7 potassium channel opener). All three drugs decreased spontaneous RGC firing,
but 18BGA and Flu also decreased the sensitivity of RGCs to optogenetic stimulation.
Nevertheless, all three drugs improved the SNR of ChR2-mediated responses. MFA
also made it easier to discern motion direction of a moving bar from RGC population
responses. Our results support the hypothesis that reduction of pathological RGC
spontaneous activity characteristic in retinal degenerative disorders may improve the
quality of visual responses in retinal prostheses and they provide insights into how best
to achieve this for optogenetic prostheses.
Keywords: retinal degeneration, retinal prosthesis, optogenetics, spontaneous activity, meclofenamic acid,
flupirtine, 18-beta-glycyrrhetinic acid
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1. Introduction
Retinitis pigmentosa (RP) is a retinal dystrophy characterized
by progressive photoreceptor death, starting with the rods,
causing night-blindness and a loss of peripheral vision, followed
eventually by total blindness as the cones start to degenerate as
well (Heckenlively et al., 1988; Berson, 1993; Hartong et al., 2006).
It has a global prevalence of approximately one in 4000 (Hartong
et al., 2006). At present, the only clinically available treatment
capable of restoring vision in RP (as opposed to slowing or
halting progression of visual loss) is retinal prosthesis. Current
retinal prostheses use implanted electrodes in combination with
photovoltaics (Mathieson et al., 2012; Stingl et al., 2013) or an
external light sensor (Dorn et al., 2013) to deliver patterned
electrical stimulation to the retina and evoke a visual percept
(Margalit et al., 2002), but thus far such devices have only
managed to restore crude vision (Dorn et al., 2013; Stingl et al.,
2013). Possible reasons for this include limited resolution due to
the low number of electrodes (presently 60–1500, Dorn et al.,
2013; Stingl et al., 2013), lack of control over the spatial spread
of charge, lack of cell-type specificity and the ability to provide
excitatory but not inhibitory stimulation (Barrett et al., 2014).
Optogenetics, in which neurons are engineered to express light-
sensitive ion channels to enable optical control of membrane
potential (Boyden et al., 2005; Bernstein and Boyden, 2011;
Deisseroth, 2011; Fenno et al., 2011), may be able to overcome
many of these limitations of electrical prostheses. Thus, the past
decade has seen considerable progress in the development of
optogenetic retinal prostheses, in which surviving inner retinal
neurons are made light sensitive to restore vision (for review, see
Busskamp and Roska, 2011; Busskamp et al., 2012; Cepko, 2012;
Sahel and Roska, 2013; Barrett et al., 2014).
However, an often overlooked problem of retinal
degenerations in retinal prosthetic research is the extensive
remodeling of the inner retina that follows photoreceptor death
(Marc et al., 2003; Jones and Marc, 2005; Marc et al., 2007),
which results in slow local field potential (LFP) oscillations in
the inner retina and rhythmic bursting of retinal ganglion cells
(RGCs). This pathological hyperactivity is observed in numerous
animal models of photoreceptor dystrophy, including the rd1
mouse (Stasheff, 2008), the rd10mouse (Goo et al., 2011; Stasheff
et al., 2011), the CRX mouse (Soto et al., 2012; Maccione et al.,
2014), and the P23H rat (Sekirnjak et al., 2009). In the rd1
mouse, lack of photoreceptor input results in the AII amacrine
cells becoming tonically hyperpolarized, revealing intrinsic,
low-frequency (approximately 10 Hz) oscillations in these cells
(Choi et al., 2014) that then spread via gap junctions through the
AII-ON bipolar cell network (Menzler and Zeck, 2011; Trenholm
et al., 2012), resulting in RGC bursting. Similar oscillations are
observed in wild-type mouse after blocking photoreceptor to
bipolar cell synapses (Trenholm et al., 2012; Choi et al., 2014).
Oscillations in the rd10 mouse are slightly lower frequency than
the rd1 but are pharmacologically similar (Biswas et al., 2014),
suggesting a similar underlying mechanism. In summary, low
frequency oscillations and increased spontaneous RGC firing
are common to numerous mouse models of photoreceptor
dystrophy and appear to share a common mechanism.
As a result, any signal delivered prosthetically may be more
difficult to distinguish against this background of higher and
more bursty spontaneous firing of RGCs in the degenerate retina.
Recently, Toychiev et al. (2013) demonstrated that blocking the
pathological spontaneous activity with the gap junction blocker
meclofenamic acid (MFA) improves the signal-to-noise ratio
(SNR) of surviving photoreceptor responses and responses to
electrical stimulation in the rd10 mouse retina (Toychiev et al.,
2013; Ivanova et al., 2015). Here, we set out to determine if the
same principle works in other models of retinal degeneration,
specifically the fast-degenerating rd1 model, and for optogenetic
stimulation. Additionally, Toychiev et al. (2013) considered only
responses to full-field illumination, so we sought to investigate
the effects of reducing spontaneous activity on responses to
spatiotemporally patterned stimulation using a novel 256-pixel
microLED (µLED) array (Grossman et al., 2010; Al-Atabany
et al., 2013). Finally, we tested a number of drugs with
different mechanisms of action to ascertain whether specific
blockade of gap-junctions is sufficient and necessary to block
these pathological oscillations or whether general reduction in
spontaneous activity can achieve the same results.
2. Materials and Methods
2.1. Experimental Animals
All experimental procedures were approved by the local ethics
committee at Newcastle University and were conducted in line
with the UK Home Office Animals (Scientific Procedures) Act
1986. C3H/HeNHsd mice (also known as rd1) were purchased
from Harlan Laboratories (Indianapolis, USA). These mice
express the naturally-occurring Pde6brd/rd mutant allele of rod
phosphodiesterase, which causes rapid rod death followed by
secondary cone loss, with virtually no surviving photoreceptors
by postnatal day 36 (P36) (Carter-Dawson et al., 1978). We
crossbred these with B6.Cg-Tg(Thy1-COP4/EYFP)9Gfng/J mice
from the Jackson Laboratory (Bar Harbor, USA), which express
the light-sensitive cation channel channelrhodopsin-2 (ChR2)
(Nagel et al., 2003; Boyden et al., 2005) in a number of cell types
through the central nervous system, including RGCs (Arenkiel
et al., 2007; Thyagarajan et al., 2010). All experimental animals
were at least second generation crosses (ChR2rd1) and were
homozygous for Pde6brd/rd and at least hemizygous for ChR2.
2.2. Electrophysiology
Mice were killed by cervical dislocation and their eyes
quickly enucleated and placed into room-temperature artificial
cerebrospinal fluid (aCSF) containing (in mM) 118 NaCl, 25
NaHCO3, 1 NaH2PO4, 3 KCl, 1 MgCl2, 2 CaCl2, and 10 glucose,
equilibrated with 95% O2 and 5% CO2 for retinal dissection.
The isolated retina was placed wholemount, RGC layer facing
down, onto a 60-channel indium tin oxide multielectrode array
(MEA; Multichannel Systems, Reutlingen, Germany). A small
piece of polyester membrane filter (5µm pores) (Sterlitech,
Kent, WA, USA) and a diamond- or ring-shaped metal weight
(Warner Instruments, Hamden, CT, USA) were placed on the
retina to improve coupling between the tissue and the electrodes.
Once in the MEA chamber, the retina was kept at 32◦C and
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continuously perfused with aCSF at 1–2 ml/min. The retina
was allowed to settle for 2 h before any recordings were taken.
Electrophysiological activity was recorded at a sampling rate of
25 kHz using MC_Rack software (Multichannel Systems).
2.3. Pharmacology
We used three drugs in our experiments. MFA is a gap-junction
blocker (Pan et al., 2007; Veruki and Hartveit, 2009) that has
previously been shown to improve SNR of light and electrical
responses of RGCs in dystrophic retinas (Toychiev et al., 2013;
Ivanova et al., 2015). Flupirtine is a Kv7 potassium channel
opener (Martire et al., 2004; Wladyka and Kunze, 2006; Yeung
et al., 2007) that has recently been shown to block spontaneous
activity in degenerate retinas by dampening intrinsic oscillations
in the AII amacrine cell (Trenholm et al., 2012; Choi et al.,
2014). MFA also affects the same potassium channel (Peretz et al.,
2005; Yeung et al., 2007), so we also tested a second gap-junction
blocker, 18-β-glycyrrhetinic acid (18BGA) (Davidson et al., 1986;
Syed et al., 2004; Pan et al., 2007; Sun et al., 2008), that to our
knowledge has no effect on the Kv7 channel. Both 18BGA and
the closely related compound carbenoxolone have been shown
to dampen rd1 spontaneous activity (Menzler and Zeck, 2011;
Trenholm et al., 2012). MFA and 18BGA were purchased from
Sigma-Aldrich (St Louis, USA); Flu from Abcam (Cambridge,
UK). Recordings were taken in control conditions, once at each
drug concentration (10, 20, 40, and 80µM) and again after
washout. Drugs were added to the aCSF: separate reservoirs
were maintained for each drug concentration. Thirty to forty-
five minutes were allowed for the drug to take effect after each
increase in concentration. Washout was between 1 and 3 h. Only
one drug was used on any given retina.
2.4. Optogenetic Stimulation
Stimuli were presented using a custom-made, 256-pixel, Gallium
Nitride microLED (µLED) array (Grossman et al., 2010; Al-
Atabany et al., 2013). Light from theµLED array was projected
through the camera port of an Olympus IX-71 inverted
microscope (Olympus, Tokyo, Japan) and focused onto the
RGC layer using a 2× objective. Each pixel covered an area of
approximately 62.5µm on the retina and hence the whole array
covered an area of roughly 1 mm2. The image of the array was
positioned so as to cover either the central 6 × 6 electrodes or
the set of electrodes showing the strongest electrophysiological
activity. Three sets of stimuli were used: full-field flashes with
durations of 5, 10, 25, 50, 75, or 100 ms presented every 2 s;
flashing squares of 1 × 1, 2 × 2, or 4 × 4 pixels presented
for 100 ms each; and bars of width 2 pixels moving in the 8
cardinal and ordinal compass directions at speeds of one pixel
every 50 or 100 ms (1250 or 625µm/s) presented every 4 s.
All stimuli were presented in control conditions and at the
highest drug concentration. Additionally, the full-field flashes
were presented at all intermediate drug concentrations and after
washout. Each set of stimuli at a given drug concentration was
presented in randomized blocks: 20 blocks for the full-fields and
10 blocks each for the flashing squares and moving bars. The
total power transmitted from theµLED array to the retina was
measured as 25.5µW using a Newport 1918-R optical power
meter (Newport Spectra-Physics Ltd, Didcot, UK) equipped with
a Newport 818-UV/DB photodiode. Averaged over the entire
(approximately 1 mm2) image this corresponds to an irradiance
of 25.5µW/mm2. In practice due to the separation between
individual LEDs there will be regions of zero irradiance and
regions of higher irradiance (equal to the average irradiance
divided by the fill factor). In one experiment, the power output
was accidentally set to 21.0µW, but the results from this
experiment were not qualitatively different from the rest and so
they were included in all analyses presented here.
2.5. Analysis
To analyse LFP oscillations, raw MC_Rack data was imported
into Matlab (The MathWorks, Natick, USA) using the FIND
toolbox. Roughly 1 min of data (specifically 83.88 s, i.e., the
number of samples (221 = 2097152) equal to the next integer
power of two greater than 1 min of recording at 25 kHz) was
extracted from the middle of each spontaneous activity recording
and its power spectrum computed. The oscillation strength was
quantified as the area under the peak of the power spectrum over
the full width at half maximum.
To analyse spontaneous firing and spiking responses to
optogenetic stimulation, spikes were first extracted by high-
pass filtering the data in MC_Rack with a cut-off of 300
Hz and then applying a voltage threshold. The threshold was
set for each channel for each retina independently as seven
standard deviations below a baseline 60 s recording from the
empty MEA at the beginning of each experiment and then
adjusted manually to ensure as many spikes were detected as
possible while minimizing noise. Spike waveforms comprising 16
samples before and 32 samples after each threshold crossing were
extracted and imported into Oﬄine Sorter (Plexon, Dallas, USA)
for spike sorting. Automatic spike sorting was performed using
T-distribution Expectation-Maximization (Shoham et al., 2003),
followed by manual inspection to ensure accuracy of sorting.
2.5.1. Detecting Optogenetically Responsive Cells
Not all RGCs in these retinas express ChR2, hence responses to
the longest-duration full-field flashes were used to detect RGCs
that responded to optogenetic stimulation. First, a spontaneous
firing distribution was bootstrapped by dividing the 1 s periods
before each flash into 100 ms bins (equal to the length of the
longest flash), computing the median number of spikes in 10
randomly selected bins and repeating this procedure 10,000
times. This distribution was used to assign one-sided p-value to
the median number of spikes fired by a cell in response to 100 ms
flashes, under the null hypothesis that the cell does not respond to
stimulation. Those cells within a recording having p < 0.05 after
false-discovery rate correction (Yoav and Hochberg, 1995) were
deemed responsive. To avoid double-dipping (Kriegeskorte et al.,
2009), only odd-numbered trials of the full-field flashes were used
to detect responsive cells and only even-numbered trials were
used to calculate thresholds and SNR (see below).
2.5.2. Stimulation Threshold and Signal-to-noise
Ratio
For each cell that was responsive in both control conditions and
at the highest drug concentration, the stimulation threshold and
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SNR were calculated as follows. The response probability as a
function of flash duration was calculated by counting the number
of trials on which the number of spikes fired in the 100 ms
following the onset of a flash exceeded the median number of
spikes fired in any 100 ms period of spontaneous activity. This
response probability function was fit with a sigmoid function
using the lsqcurvefit function in Matlab:
p(t) = 1
1+ e− t−ba
The parameter b gives flash duration with a 50% probability
of evoking a response, which was taken as the threshold for
a given cell. The signal-to-noise ratio (SNR) is commonly
defined as the mean of the signal divided by the standard
deviation of the noise. The signal we are interested in
here is those spikes evoked by the µLED flash, but it
is impossible to distinguish stimulus-evoked spikes from
spontaneous spikes that happened to be fired immediately
after a stimulus, hence we estimated the SNR for a given
cell as
SNR = µsignal+noise − µnoise
σnoise
Where µsignal+noise is the mean number of spikes (spontaneous
and evoked) fired in the 100 ms following any even-numbered
flash, µnoise is the mean number of spikes fired in any 100
ms bin of spontaneous activity and σnoise is the standard
deviation of the number of spikes fired in any 100 ms bin
of spontaneous activity. Some RGCs in each recording only
fired immediately following a flash and so their SNR was
immeasurably high: these cells were assigned an SNR of
infinity.
2.5.3. Spike Triggered Averaging and Receptive Field
Measurement
Responses to the 2× 2 and 4× 4 pixel flashed squares were used
to construct spike-triggered averages (STAs) for each cell (the 1
× 1 pixel flashes were found to produce very weak responses, if
any, and so were excluded from the STA). A 16 × 16 matrix of
zeros—one entry perµLED pixel—was instantiated for each cell.
For each frame of each stimulus, the number of spikes fired by
that cell during presentation of that stimulus frame was added
to those matrix entries corresponding to the pixels that were on
during that frame. Finally, each entry in thematrix was divided by
the number of stimulus frames in which the corresponding pixel
was on. Each STA was fit with a raised two-dimensional Gaussian
function using Matlab’s lsqcurvefit function:
a = cos
2 θ
2σ 2x
+ sin
2 θ
2σ 2y
b = − sin 2θ
4σ 2x
+ sin 2θ
4σ 2y
c = sin
2 θ
2σ 2x
+ cos
2 θ
2σ 2y
RF(x, y) = Ae−(a(x−xc)2+2b(x−xc)(y−yc)+c(y−yc)2) + B
The receptive field radius was then calculated as the geometric
mean of the semimajor and semiminor axes of the 1-SD contour
of the fitted Gaussian, i.e., r = √σxσy. This corresponds
to the radius of a circle having the same area as the fitted
receptive field. The receptive field aspect ratio was calculated
as σy/σx.
2.5.4. Moving Bars
Each cell’s spike train during the presentation of the moving
bar stimuli was convolved with a one-dimensional Gaussian
function with a standard deviation of 25 ms to estimate the
instantaneous firing rate (IFR). The time to peak firing on each
trial was calculated as the time between the appearance and
disappearance of the bar that the IFR reached its maximum
value, relative to bar onset. If a cell only fires when a sufficient
amount of light falls within its receptive field, this time to peak
firing should provide a reliable estimate of the point along the
bar’s trajectory at which it entered the cell’s receptive field. If the
cell’s receptive field is not exactly in the middle of the array, this
will also give some information as to the direction of travel of
the bar.
To quantify how well the population of optogenetically
sensitive cells in a given retina encodes stimulus direction, a
modified naive Bayesian classifier was trained to determine bar
direction. Given a set of observations r = {r1, ..., rN} that can
belong to a class s ∈ {s1, ..., sk}, a Bayesian classifier attempts to
assign the response to the most likely class sˆ using Bayes’ rule,
assuming that the random variables (or “features”) that comprise
the observation are conditionally independent:
sˆ = argmax
s
p(s|r) = argmax
s
p(r|s)p(s)
p(r)
= argmax
s
p(s)
N∏
i=1
p(ri|s)
(Note that the denominator is irrelevant because it is the
same for all classes.) Here, each feature is the response of
one RGC (quantified as time to peak firing) and each class
is the direction of the moving bar that evoked that response.
All RGCs that responded in control or drug conditions were
included in the classifier. A typical naive Bayesian classifier
assumes each p(ri|s) follows a Gaussian distribution. However,
on some trials, particularly in the drug condition, cells
do not fire and therefore the time to peak firing is not
defined, so we treat it as infinite. To account for this, each
RGC’s response conditioned on the stimulus direction was
assumed to be a mixture of a discrete, Bernoulli-distributed
random variable (response or no response) and a continuous,
Gaussian-distributed random variable (time to peak firing, if
finite):
p(r|s) =
{
qs if r = ∞
(1− qs)g(r;µs, σs) if r < ∞
where r is the time to peak firing of the cell, s is the bar
direction, g(r;µs, σs) is the probability density function of a
random variable following a Gaussian distribution with mean
µs and variance σ
2
s , and 0 ≤ qs ≤ 1. It is trivial to show
that, given a sample {x1, ..., xm, y1, ..., yn} (where xi = ∞ for
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all 1 ≤ i ≤ m) of observations from the above distribution,
the maximum likelihood estimator (MLE) of qs is
m
m+n and
the MLEs of µs and σs are the mean and standard deviation
of {y1, ..., yn}, respectively. p(s) followed a uniform distribution
with eight values, i.e., p(s) = 1/8 for all s.
Each set of bar responses was partitioned into a training set
and a test set. The training set was used to estimate p(r|s) =∏N
i=1 p(ri|s). The decoder performance is the percentage of test
trials in which sˆ equals the stimulus that was actually presented.
This is repeated for multiple instantiations of training and test
sets to obtain an average decoder performance. We used leave-
one-out cross-validation, in which the size of the test set is always
one, the training set is every trial apart from the test trial, and
each trial is used as the test set exactly once.
2.5.5. Statistical Analysis
All analyses presented here are non-parametric repeated
measures designs with drug concentration as the within-subjects
factor, so the Friedman test was used. Different retinas were
used as the blocking factor except where noted in the text.
Where multiple measurements were taken from a single retina
(i.e., multiple channels or multiple cells), the median value
for each retina was used in the analysis. As the Friedman
test operates on ranks, infinite SNR values were assigned the
mean of the rank they would have been assigned had they
been finite, monotonically increasing values greater than any
measurable SNR value. Due to the uneven number of retinas
used for each drug for some analyses, separate tests were
used for each drug and so no direct statistical comparisons
between drugs are presented here (although the Friedman
test does not assess the significance of between-subject effects
anyway). All p-values are reported uncorrected, but all those
significant at the p < 0.05 level remained significant after
Holm-Bonferroni correction for multiple comparisons with an
α level of 0.05.
3. Results
3.1. Spontaneous Activity and Full-field
Stimulation
Figure 1 shows raw traces recorded from one channel in control
conditions and in the presence of 20µM and 80µM MFA, as
well as the power spectra from this same channel at each drug
concentration. There is a clear decrease in oscillatory activity
and spontaneous firing as the drug concentration increases. This
pattern held across all retinas for all three drugs tested. Each drug
significantly reduced the strength of LFP oscillations (Friedman
test: 18BGA n = 7, p = 2.5 × 10−5; Flu n = 7, p = 0.0001;
MFA n = 7, p = 6 × 10−6) and spontaneous RGC firing
(Friedman test: 18BGA n = 7, p = 1.1 × 10−5; Flu n =
7, p = 6 × 10−6; MFA n = 7, p = 1.5 × 10−5). Figure 2 shows
the effect of each drug on oscillation strength and spontaneous
firing rate relative to control conditions averaged across all
recorded channels for all retinas. Flu has a stronger effect at
low concentrations, consistent with a previous study showing
that 10µM Flu blocks spontaneous activity (Choi et al., 2014),
but for all three drugs spontaneous firing is almost completely
abolished at 80µM. There is substantial recovery of oscillations
and spontaneous firing after washout of Flu and MFA, consistent
with previous reports (Menzler and Zeck, 2011; Trenholm et al.,
2012; Choi et al., 2014), but not with 18BGA, the effects of which
are known to be irreversible at high concentrations (Rozental
et al., 2001).
Lowering spontaneous activity has the potential to improve
SNR, but not if it comes at the expense of the ability to stimulate
RGCs optogenetically. Figure 3 shows the number of cells that
respond to the longest full-fieldµLED array flash at each drug
concentration, relative to control conditions. All three drugs
significantly affected the number of responsive cells (18BGA
n = 7, p = 0.0037; Flu n = 7, p = 0.0019; MFA n =
7, p = 0.0058). 18BGA and Flu both caused a dose-dependent
A
B
C
D
FIGURE 1 | (A–C) Raw electrode trace on one channel for an example
retina in control conditions (A), with 20µM MFA (B), and with 80µM
MFA (C). Note the decrease in both oscillations and level of
spontaneous firing as the drug concentration increases. (D) Power
spectra recorded on the same channel in control conditions, at each
drug concentration and after washout. Notice the overall decrease in
LFP power as the drug concentration increases and the recovery upon
washout.
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A B
FIGURE 2 | (A) Spontaneous firing rate as a percentage of control
conditions for each concentration of all three drugs, averaged over all
channels with recorded spikes and all retinas. (B) Oscillation strength as a
percentage of control conditions for each concentration of all three drugs,
averaged over all recorded channels and all retinas. For both figures, error
bars show the interquartile range (IQR).
FIGURE 3 | Number of cells responding to the longestµLED array flash
at each drug concentration as a percentage of control conditions,
averaged over all retinas.
decrease in the number of responsive cells (in one experiment
for each, there were no responding cells left at 80µM and so
these experiments were excluded from the threshold and SNR
analyses). The pattern for MFA is more complicated: at most
concentrations, the number of responsive cells was similar to
control conditions, but the number of responsive cells appears to
increase at 40µMbefore returning to baseline at 80µM. Figure 4
shows the threshold flash duration for those cells that responded
to optogenetic stimulation in both control conditions and the
highest drug concentration. All three drugs appear to cause a
dose-dependent increase in stimulation thresholds (18BGA n =
6, p = 0.0097; Flu n = 6, p = 0.0002; MFA n = 7, p = 0.0087).
Taken together, these results suggest that 18BGA and Flu hinder
optogenetic stimulation of RGCs, whereas MFA has a mixed
effect, increasing the number of responsive cells at the expense
of increasing the stimulation threshold.
Figure 5 shows raster plots and PSTHs from an example cell
in response to the longest flash in control conditions and at the
highest drug concentration. It is very difficult to distinguish the
cell’s response from the high level of spontaneous activity in
control conditions, but the response to light is very distinct once
the spontaneous activity is abolished. Figure 6 shows SNR as a
function of drug concentration for those cells that responded in
control conditions and at 80µMand hadmeasurable SNR values.
Note that some responsive cells did not fire any spontaneous
spikes during the recording and hence we could not estimate
their SNR and so the values in the figure are underestimates.
These cells were assigned an SNR of infinity for the purpose of
statistical analysis (see Section 2.5.5). In four retinas each for
Flu and MFA, over half the responsive cells had infinite SNR at
80µM. All three drugs significantly increased SNR (Friedman
test, flash duration as blocking factor: 18BGA n = 6, p = 0.0004;
Flu n = 6, p = 1.2× 10−7; MFA n = 7, p = 3.7× 10−7).
3.2. Spatiotemporally Patterned Stimulation
Figure 7 shows example STAs recovered from responses
to flashing squares in control conditions and at a drug
concentration of 80µM. In both cases, a clear hotspot is
observed, presumably corresponding to those pixels that overlap
the RGC, but the surrounding pixels are slightly noisier in
control conditions. This pattern was similar across all cells
for which responses to flashing squares were successfully
recorded. The median receptive field diameter was 245.2µm
in control conditions and 219.8µm in the drug condition, but
this difference was not significant. In both control and drug
conditions the recovered RFs were mostly roughly circular, with
a median aspect ratio of 1.17. ChR2 in these retinas is expressed
throughout the cell (data not shown, see also Thyagarajan et al.,
2010), including soma, dendrites, and axons. The size and shape
Frontiers in Cellular Neuroscience | www.frontiersin.org 6 August 2015 | Volume 9 | Article 330
Barrett et al. Blocking hyperactivity improves optogenetic stimulation
of the ChR2 receptive fields is consistent with ChR2 activation
in the soma and dendrites being primarily responsible for spike
generation, rather than axonal stimulation, even though the light
had to pass through the nerve fiber layer before reaching the
RGCs.
Figure 8 shows responses of an example cell to four directions
of the moving bar stimulus, in control and drug conditions. It
is difficult to discern the response to the bar in the presence of
spontaneous hyperactivity, but there is a clearly distinguishable
peak in the cell’s firing when the bar enters its receptive field
in the drug condition. Nevertheless, the Bayesian classifier was
modestly successful in decoding stimulus direction in control
conditions, achieving correct decoding roughly 40–70% of the
FIGURE 4 | Threshold flash duration for optogenetically sensitive cells
at each drug concentration. Data points are median over all retinas of the
median threshold of all cells that respond in both control conditions and at
80µM drug. Error bars are IQR for all retinas.
time on average (Figure 9, blue bars). After applying the drug, the
decoder performance is improved, with the classifier decoding
the stimulus direction correctly 70–100% of the time on average
(Figure 9, red bars). This difference was significant for MFA
(Friedman’s test, bar speed as blocking factor: n = 7, p = 0.0001)
but not Flu (n = 7, p = 0.44) or 18BGA (n = 7, p = 0.57).
4. Discussion
4.1. Blocking Spontaneous Activity Improves
SNR Regardless of the the Mechanism of Action
It has been shown recently that blocking spontaneous activity
with MFA improves SNR of residual photoreceptor responses
and responses to electrical stimulation in the rd10 mouse
(Toychiev et al., 2013; Ivanova et al., 2015). Our results show
that this principle also holds for optogenetic stimulation in the
rd1mouse. Spontaneous activity in degenerate retinas is believed
to originate in the AII amacrine cell (Trenholm et al., 2012;
Choi et al., 2014) and propagate through the retinal network
via gap junction coupling between AII amacrine cells and other
cell types, such as ON-cone bipolar cells (Menzler and Zeck,
2011; Trenholm et al., 2012; Yee et al., 2012). These oscillations
can be strengthened or dampened by altering the potassium
conductance of AII cells (Choi et al., 2014), and prevented from
spreading by blocking gap junctions (Menzler and Zeck, 2011;
Trenholm et al., 2012; Toychiev et al., 2013; Biswas et al., 2014).
MFA is both a gap-junction blocker (Pan et al., 2007) and
a modulator of Kv7 potassium channels (Peretz et al., 2005;
Yeung et al., 2007), so it is not clear which of these mechanisms
is responsible for its effects on spontaneous hyperactivity. In
principle, it should not matter for improving SNR, but to confirm
this we tested two additional drugs: Flu, which is a powerful
Kv7 potassium channel opener (Martire et al., 2004; Wladyka
and Kunze, 2006; Yeung et al., 2007) that has recently been
A B
FIGURE 5 | (A) Raster plot and PSTH of an example cell in
response to 100ms full-fieldµLED flashes in control conditions. The
light is on between the red dotted lines. It is difficult to distinguish
the evoked responses from the spontaneous bursts that occur
randomly between stimuli. (B) Raster plot and PSTH of the same
cell in response to the same stimulus in the presence of 80µM
MFA. The spontaneous activity is abolished and the evoked
response is very distinct.
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shown to block rd1 spontaneous activity (Choi et al., 2014); and
18BGA, another gap junction blocker (Davidson et al., 1986).
As expected, all three drugs significantly reduced spontaneous
FIGURE 6 | Signal-to-noise ratio for responses to the longestµLED
array flash at each drug concentration. Data points are median over all
retinas of the median SNR of all cells that respond in both control conditions
and at 80µM drug and had measurable SNR values. Error bars are IQR for all
retinas.
firing and improved SNR of optogenetic responses, at least for
those cells that were still sensitive to ChR2 stimulation. These
results demonstrate that being able to suppress the pathological
spontaneous activity, rather than the specific approach to do
so, is the key requisite to enhance the SNR during electrical
or optogenetic stimulation. In principle, any other means of
blocking spontaneous activity, for example blocking synaptic
input onto RGCs (Borowska et al., 2011; Menzler and Zeck, 2011;
Trenholm et al., 2012; Biswas et al., 2014), should also improve
the SNR of optogenetic responses, although we have not tested
this.
4.2. Effects on Stimulation Efficiency of ChR2
RGCs
Increasing the SNR of individual cells by decreasing spontaneous
activity may not lead to improved prosthetic signal transmission
through the retina if the method of decreasing spontaneous
activity also leads to fewer cells responding to stimulation. Hence,
we measured the number of cells responding to stimulation and
their stimulation threshold as a function of drug concentration.
Both 18BGA and Flu appear to lead to a dose-dependent decrease
in the number of cells responding and an increase in stimulation
thresholds. In the case of Flu, this may be because it acts by
increasing the conductance of the Kv7 potassium channel (Peretz
et al., 2005; Yeung et al., 2007; Choi et al., 2014). If these
A B
C D
FIGURE 7 | (A) Spike triggered average for an example RGC in control conditions. (B) Spike triggered average for the same cell in the presence of 80µM MFA. (C,D)
Gaussian fits to the data in (A,B). The scale bar in each panel is oneµLED array pixel or approximately 62.5µm in length.
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A B C D
E F G H
FIGURE 8 | Raster plots and PSTHs for an example in response to
bars moving in the four cardinal compass directions at 625µm/s in
control conditions (A–D) and in the presence of 80µM MFA (E–H). The
bar appears at the first red dotted line, sweeps across the array, and
disappears at the second red dotted line. On a trial-by-trial basis, random
spontaneous bursts may corrupt the estimate of time to peak firing and
hence when the bar enters the cell’s receptive field. After blocking
spontaneous activity, the cell only fires when the bar passes over its receptive
field. This cell was located at the north-east corner of the array, so it reaches
its peak firing rate very soon after bar onset when the bar starts in the north
or east of the array (A,B,E,F), but very late when the bar originates in the
south or west (C,D,G,H).
A B
FIGURE 9 | (A) Bayesian decoder performance for responses to the
1250µm/s bars in control conditions (blue bars) and in the presence of
80µM of each drug (red bars). Decoder performance is much higher in the
presence of the drug. Dotted line indicates chance level performance. (B) the
same plot for the 625µm/s bars. For both panels, data points are medians
over all retinas and error bars are IQRs.
potassium channels are present on RGCs, application of Flu
could lead to a lower resting membrane potential and a decrease
in excitability, which would explain the observed effects. In line
with this hypothesis, unpublished data from our lab shows that
increasing RGC excitability by raising the extracellular potassium
concentration leads to lower ChR2 stimulation thresholds. Why
18BGA should also increase stimulation thresholds is not clear,
but as well as blocking gap junctions it affects a number of
other ion channels (Rozental et al., 2001; Juszczak and Swiergiel,
2009) and possibly one of these effects is responsible for the
increase in thresholds. 18BGA is also apparently cytotoxic at
high concentrations (above 75µM; Rozental et al., 2001), which
might explain the sharp increase in threshold between 40µMand
80µM.
MFA has mixed effects on stimulation efficiency of ChR2-
expressing RGCs. Like 18BGA and Flu, it increases thresholds
in a dose-dependent manner, possibly also through the effect on
the Kv7 channel that it shares with Flu (Yeung et al., 2007; Choi
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et al., 2014). Unlike the other two drugs, at 40µM it increases
the total number of cells with detectable responses. This increase
may simply be due to unmasking of weak responding cells that
could not be distinguished above the spontaneous activity. If,
however, this increase in responders is a specific pharmacological
effect of MFA, one possibility is that blocking gap junctions
prevents ChR2 currents leaking into neighboring, non-ChR2-
expressing RGCs, producing a stronger depolarization in the
ChR2 RGC. In either case, the further increase in thresholds at
80µM MFA seems to counteract the increase in responsiveness
so that the number of responding cells returns to baseline. As
such, moderate concentrations of MFA (similar to those used by
Toychiev et al., 2013) seem to offer the best trade-off between
improving SNR by decreasing spontaneous activity and not
hindering ChR2 stimulation.
4.3. Spatiotemporally Patterned Stimulation of
Optogenetically Sensitive Retinas
The above analyses concern responses to wide-field, spatially
homogenous flashes, which are not particularly perceptually
interesting stimuli. Most visual tasks involve discerning
information from a scene in which the pattern of light is varying
in both space and time. Hence we also investigated, for the
first time, the effects of decreasing spontaneous activity on
spatiotemporally patterned optogenetic stimulation.
First, we mapped the receptive fields of ChR2-sensitive
RGCs using spike-triggered averaging, or reverse correlation,
of responses to small (2 × 2 or 4 × 4 pixels), brief flashes.
Limitations of the stimulation device prevented the use of
more typical reverse correlation stimuli, such as white noise
(Chichilnisky, 2001), but nonetheless we were able to capture
clear receptive fields in both control conditions and after
blockade of spontaneous activity. The similarity of the recovered
receptive fields in both conditions is more likely a testament
to power of reverse correlation as a technique than evidence
against the hypothesis that blocking spontaneous activity
improves prosthetic responses. The recovered receptive fields
were unipolar (as expected, since ChR2 is purely excitatory),
slightly elliptical, and had an average diameter of 200–250µm,
which is on par with typical RGC dendritic arbor sizes (Sun et al.,
2002). This is unsurprising: expression of ChR2 in the RGCs
of this particular mouse line is throughout the cell membrane,
including soma, dendrites, and axons (data not shown, see also
Thyagarajan et al., 2010). One would thus expect the amount of
depolarization caused by ChR2 stimulation to be proportional to
the total cell surface area covered by the light stimulus, hence the
response would be strongest when the light covers the soma and
dendrites.
We also tested how well the population of optogenetically
sensitive RGCs encodes spatiotemporal stimulus properties,
namely motion direction of a moving bar. To measure this, we
used Bayesian classification, which provides a lower bound on
the information carried by a neural response about a stimulus
(Quian Quiroga and Panzeri, 2009) and has been used previously
to compare different retinal coding strategies to behavioral
performance (Jacobs et al., 2009). The decoder was based on
each cell’s time to peak firing after stimulus onset, which in the
absence of noise should correspond to when the bar crosses
the cell’s receptive field. It also took all cells as conditionally
independent given the stimulus (the naive Bayesian assumption),
which is plausible as the only stimulus-driven input each ChR2
RGC in a blind retina should receive is from the activation of
ChR2 itself. Under these assumptions, the decoder performed
much better when there was less spontaneous activity. This
improvement was statistically significant for MFA, but not
18BGA or Flu. The lack of improvement for 18BGA and Flu
might be because high concentrations of these drugs reduce
the number of optogenetically responsive cells: many low SNR
cells might encode motion direction just as well as a few
high SNR cells. Flupirtine is effective at lower concentrations
than 18BGA or MFA (Figure 6; see also Choi et al., 2014),
so in one experiment we recorded moving bar responses at
0 and 20µM Flu, but despite vastly reduced spontaneous
activity, the decoder performance was virtually identical (data not
shown). Thus, these data support that conclusion that blockade
of spontaneous activity with MFA improves the encoding of
spatiotemporal information available in optogenetically-evoked
RGC responses. However, as we have only tested this using one
set of stimuli, further investigation using different stimuli and
encoding strategies will be needed to confirm this.
4.4. Implications for Treatment of Retinal
Degenerations
This study adds more evidence to the idea that reducing
spontaneous hyperactivity in degenerate retinas could potentially
improve the quality of vision returned by retinal prosthetics and
that this is a worthwhile avenue to pursue in the search for
improved treatments for retinal dystrophies such as RP. Further,
by investigating a number of drugs we have provided information
as to best choice of drug if a pharmacological strategy is
chosen to reduce spontaneous activity in retinal prosthetic
patients (but see below). Flu is an analgesic, anticonvulsant and
muscle relaxant that is currently being investigated for possible
neuroprotective effects (Friedel and Fitton, 1993; Klawe and
Maschke, 2009; Szelenyi, 2013), MFA is a non-steroidal anti-
inflammatory drug and analgesic (Juszczak and Swiergiel, 2009),
and 18BGA is a flavoring agent derived from licorice (Asl and
Hosseinzadeh, 2008). Thus, all three drugs are at least safe for
human consumption and, in the case of Flu and MFA, already
clinically approved drugs. However, given the apparent negative
effects of 18BGA and Flu on ChR2 stimulation, MFA is probably
the best candidate, at least where optogenetic retinal prostheses
are concerned. There is some evidence that MFA is retinotoxic
(Sun et al., 2013), but only at concentrations much higher than
those used in this study. In particular, concentrations of around
40–50µM seem to be effective at improving prosthetically-
evoked responses without adverse effects either on optogenetic
stimulation or the retina itself.
4.4.1. How Best to Dampen Spontaneous
Hyperactivity?
There may be problems with a pharmacological strategy to
decrease spontaneous activity and improve prosthetic vision in
a clinical setting. In particular, there is the challenge of delivering
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sustained, controlled, targeted dosages of the chosen drug to
the retina. Systemic administration of both Flu and MFA can
have a number of unpleasant side effects (Friedel and Fitton,
1993; Juszczak and Swiergiel, 2009; Klawe and Maschke, 2009;
Szelenyi, 2013), as can excessive consumption of licorice, of
which 18BGA is a metabolite (Asl and Hosseinzadeh, 2008;
Juszczak and Swiergiel, 2009). These negative side-effects may
not be a worthwhile trade-off, especially if the improvement in
vision is modest. An alternative might be intravitreal injection,
but if the chosen compound washes out in a matter of hours, as
is the case for Flu andMFA in-vitro, then this would obviously be
impractical. One solutionmight be to deliver the drug in the form
of a slow-release compound that remains in the eye and releases
the drug at a controlled rate, but this may be a considerable
biomedical engineering challenge.
Fortunately, in this study we have shown that multiple drugs
block spontaneous activity and improve SNR, independently
of the mechanism of action. Extending this principle, it may
be that non-pharmacological strategies to decrease spontaneous
activity would also improve vision, while avoiding the challenges
described above. For example, if increasing the potassium
conductance of AII amacrine cells decreases spontaneous activity
(Choi et al., 2014), then gene therapy to increase Kv7 potassium
channel expression in AIIs or introduce a modified form of the
channel with higher conductance might have a similar effect
to Flu or MFA. Moreover, if the chosen promoter is selective
for AIIs, then it would avoid the decrease in responsiveness
observed with high concentrations of Flu. Genetic knock-out
of gap junctions could also work (Ivanova et al., 2015), but it
would be better to restrict the knock-out to AIIs rather than pan-
retinally as gap-junctions play a number of important roles in
vision (Bloomfield and Völgyi, 2009). Alternatively, in the case of
an optogenetic retinal prosthesis, one could envisage expressing
an inhibitory opsin with a distinct absorption spectrum, such as
halorhodopsin, in the AIIs and using a steady background light
to hyperpolarize them and dampen the oscillations. However,
this would increase the power consumption of the prosthetic
device.
4.4.2. How Much Does the Prosthetic Strategy
Matter?
The results from this study, combined with the work of
Toychiev et al. (2013) and Ivanova et al. (2015), suggest that
blocking spontaneous activity to improve prosthetic vision
works as a general strategy, somewhat independently of the
means of vision restoration. It has now been shown to work
for residual photoreceptor responses, electrical stimulation and
optogenetic stimulation. Thus, this strategy should be effective
for electrical prostheses, optogenetic prostheses and even non-
prosthetic strategies such as strategies to halt photoreceptor
death (e.g., Cuenca et al., 2014) or replace them with
exogenously grown or endogenously regenerated photoreceptors
(e.g., Jayakody et al., 2015). However, the method of vision
restoration has some implications for the choice of strategy
for block spontaneous activity. Blocking gap-junctions with
MFA is fine for an epiretinal electrical prosthesis or RGC-
targeting optogenetic process, whereby we assume the inner
retina is incorrigibly degenerated and thus stimulate the RGCs
directly, perhaps with the help of a retina-mimicking encoder
(Nirenberg and Pandarinath, 2012). However, photoreceptor-
preserving/replacing approaches, subretinal electrical prostheses
and bipolar-cell targeting optogenetic prostheses all rely on an
intact inner retina to encode the visual scene in a way the
brain can understand. Setting aside the question of whether
inner retinal function is preserved in retinal degeneration (Marc
et al., 2003; Jones and Marc, 2005; Marc et al., 2007; but see
also Busskamp et al., 2010), the AII amacrine cells (Farsaii
and Connaughton, 2011) and gap junctions (Bloomfield and
Völgyi, 2009) both have important roles in normal visual
function and interfering with them to reduce spontaneous
activity may corrupt the visual signal sufficiently to bring
no net gain in quality of restored vision. Choi et al. (2014)
suggest that restoration of photoreceptor light responses or light-
sensitization of bipolar cells might bring the AIIs into a more
depolarized, non-oscillating regime, but this depends on the
amount of depolarization introduced by the light sensitization.
Hence whether spontaneous activity reduction is beneficial in
photoreceptor- or bipolar cell-targeting treatments remains an
open question.
4.5. Light Requirements
Retinal degenerate spontaneous hyperactivity has been largely
overlooked in previous studies of optogenetic retinal prosthesis.
One possible explanation for this is the light intensities used.
Most reports are accompanied by dramatic rasters of light
responses, where the peak in the PSTH towers above what
appears to be an insignificant baseline firing rate (Bi et al.,
2006; Lagali et al., 2008; Zhang et al., 2009; Busskamp et al.,
2010; Doroudchi et al., 2011). The average irradiance at the
level of the retina in this study was around 25µW/mm2 or
approximately 6.3 × 1015 photons/s·cm2 at 490 nm (the peak of
the µLED array emission spectrum), which is at the lower end
of light intensities typically used in studies of optogenetic retinal
prostheses (but compare Lin et al., 2008; Cehajic-Kapetanovic
et al., 2015; van Wyk et al., 2015; also, as noted in Section 2.4,
the peak irradiance at the retinal level in this study will be higher,
but not by more than half a log unit). The implications for this
are two-fold. Firstly, being able to evoke visual responses with
lower light intensities lowers the overall power requirements of
the retinal prosthetic device. Moreover, if a prosthesis needs to
drive the retina very strongly to produce a reliable percept, then
this suggests that it will only be able to transfer information
about high-contrast visual features, making them no better than
currently available devices and necessitating image processing
strategies to improve scene contrast (e.g., Al-Atabany et al.,
2013). Decreasing the amount of spontaneous activity may
allow lower-contrast visual features to be perceived, improving
the dynamic range of retinal prosthetic devices. Ultimately
psychophysical studies in prosthetic patients will be needed to
determine whether this is indeed the case.
4.6. Conclusions
We have demonstrated that reducing spontaneous activity works
as a strategy to improve the quality of optogenetically-evoked
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retinal responses, increasing the SNR of optogenetic responses
and improving the ability to determine stimulus properties
from RGC firing. Moreover, of the drugs tested so far, we
have shown that MFA is the most promising in terms of
decreasing spontaneous activity without hampering optogenetic
stimulation. This provides important information and guidance
for future research into improving the quality of vision returned
by retinal prosthetics.
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